you are here:

Eris Lifesciences Ltd.

BSE: 540596 | NSE: ERIS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406M01024 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Sep 22, 16:00
747.00 -10.60 (-1.40%)
Volume
AVERAGE VOLUME
5-Day
10,488
10-Day
6,943
30-Day
7,421
3,199
  • Prev. Close

    757.60

  • Open Price

    759.00

  • Bid Price (Qty.)

    747.00 (8)

  • Offer Price (Qty.)

    749.10 (2)

NSE Live

Sep 22, 15:53
750.25 -7.30 (-0.96%)
Volume
AVERAGE VOLUME
5-Day
127,032
10-Day
85,219
30-Day
76,216
50,623
  • Prev. Close

    757.55

  • Open Price

    760.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    750.25 (30)

Financials

2020 2019 2018 2017 2016
Profit & Loss account of Eris Lifesciences (in Rs. Cr.) Mar 21 Mar 20 Mar 19 Mar 18 Mar 17  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 1,088.65 1,003.76 881.13 732.34 688.42  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 1,088.65 1,003.76 881.13 732.34 688.42  
Total Operating Revenues 1,108.83 1,020.23 896.54 760.60 712.90  
Other Income 10.00 14.73 32.50 28.22 25.08  
Total Revenue 1,118.83 1,034.96 929.04 788.82 737.98  
EXPENSES  
Cost Of Materials Consumed 99.43 76.88 58.19 47.08 45.38  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -12.57 17.47 -13.40 -3.54 8.09  
Employee Benefit Expenses 207.02 191.73 166.77 130.85 116.31  
Finance Costs 0.78 1.85 22.79 10.43 0.80  
Depreciation And Amortisation Expenses 37.64 44.88 31.59 21.79 21.44  
Other Expenses 285.99 308.54 263.76 205.44 218.75  
Total Expenses 729.94 711.37 617.26 476.94 464.00  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 388.89 323.59 311.78 311.89 273.99  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 388.89 323.59 311.78 311.89 273.99  
Tax Expenses-Continued Operations  
Current Tax 70.18 57.49 68.87 67.95 55.76  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -31.90 -25.17 -42.47 -49.71 -29.92  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 38.29 32.32 26.40 18.23 25.84  
Profit/Loss After Tax And Before ExtraOrdinary Items 350.61 291.27 285.38 293.66 248.14  
Profit/Loss From Continuing Operations 350.61 291.27 285.38 293.66 248.14  
Profit/Loss For The Period 350.61 291.27 285.38 293.66 248.14  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 25.82 21.23 20.75 21.36 18.05  
Diluted EPS (Rs.) 25.80 21.21 20.74 21.36 18.05  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 74.68 38.97 0.00 0.00 0.00  
Tax On Dividend 0.00 8.01 0.00 0.00 0.00  
Equity Dividend Rate (%) 550.00 287.00 0.00 0.00 0.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

No News.
No News.
No News.
No News.